High homocysteine is also an established risk factor for both AD and TBI [39, 78–80] and has been suggested to increase β-amyloid and tau pathology, protein aggregation as well as mitochondrial dysfunction involving oxidative stress pathways [81–84]. This evidence concerns the gene MAPT and Alzheimer disease.